Cordatus Wealth Management LLC Gilead Sciences, Inc. Transaction History

Cordatus Wealth Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	BUY	$59.54 - $68.01 $28,817 - $32,916	484 Added 3.5%	14,322 $884,000
Q2 2022 Aug 24, 2022	BUY	$57.72 - $65.01 $5,252 - $5,915	91 Added 0.66%	13,838 $855,000
Q1 2022 May 06, 2022	BUY	$57.92 - $72.58 $796,226 - $997,757	13,747 New	13,747 $817,000
Q2 2020 Jul 21, 2020	SELL	$72.34 - $84.0 $3.42 Million - $3.97 Million	-47,229 Closed	0 $0
Q1 2020 Apr 21, 2020	BUY	$62.63 - $80.22 $2.96 Million - $3.79 Million	47,229 New	47,229 $3.53 Million

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Cordatus Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Cordatus Wealth Management LLC with notifications on news.